TTNP - TITAN PHARMACEUTICALS INC

4.61
-0.180   -3.905%

Share volume: 3,358,220
Last Updated: 10-01-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.17%

PREVIOUS CLOSE
CHG
CHG%
$4.79
-0.18
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
41%
Profitability 25%
Dept financing 38%
Liquidity 49%
Performance 55%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
12.99%
1 Year
40.55%
2 Year
-39.68%
Key data
Stock price
$4.61
P/E Ratio 
0.00
DAY RANGE
$4.55 - $4.80
EPS 
-$2.98
52 WEEK RANGE
$3.20 - $5.76
52 WEEK CHANGE
$40.55
MARKET CAP 
3.840 M
YIELD 
N/A
SHARES OUTSTANDING 
1.330 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
-0.47
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: David E. Lazar
Region: US
Website: titanpharm.com
Employees: 10
IPO year: 2006
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company was incorporated in 1992 and is based in South San Francisco, California.

Recent news